Ylanan, Almari Faith C.

HRN: 28-62-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
CEFUROXIME 750MG (VIAL)
03/03/2026
03/10/2026
IV
200mg
Q8hours
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines